Clearline Capital »

Cytomx Therapeutics shares owned by Clearline Capital

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Clearline Capital from 13F filings

Historical chart of Clearline Capital investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Clearline Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Clearline Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $305k 197k 1.55
2023-09-30 $254k 197k 1.29
2023-06-30 $338k 197k 1.72
2023-03-31 $297k 197k 1.51
2022-12-31 $315k 197k 1.60
2022-09-30 $285k 197k 1.45
2022-06-30 $360k 197k 1.83
2022-03-31 $509k 191k 2.67
2021-12-31 $628k 145k 4.33